Effective airway clearance remains a cornerstone of management for patients with chronic mucus retention, including those with cystic fibrosis (CF), non–CF bronchiectasis, ...
.png "GEN-4626 Providers Page - Clinical Hub Main (1)")
Nocturnal hypoxemia is a frequent yet under-recognized physiologic consequence of chronic obstructive pulmonary disease (COPD). Even in patients who maintain adequate oxygenation ...
Few areas of respiratory medicine have faced as much challenge as chronic obstructive pulmonary disease (COPD) drug development. Despite decades of work, COPD remains a leading ...
Artificial intelligence (AI) has progressed rapidly from concept to operative tool across respiratory and sleep medicine. The convergence of large, annotated sleep datasets, ...
Managing Chronic Obstructive Pulmonary Disease (COPD) isn’t just about taking medications—it’s about building a care team, fostering understanding, and creating routines that ...
Pharmacologic management of chronic obstructive pulmonary disease (COPD) centers on the use of inhaled bronchodilators and occasionally corticosteroids, delivered primarily ...
Chronic Obstructive Pulmonary Disease (COPD) is a major public health challenge, affecting millions of people worldwide. According to Ford et al. (2013), COPD is a leading cause ...
Chronic Obstructive Pulmonary Disease (COPD) is a debilitating condition that affects millions of people globally, significantly impacting their quality of life. As healthcare ...
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that significantly impacts patients’ quality of life. Effective management of COPD goes beyond medical ...
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that significantly impacts patients’ quality of life. Effective management of COPD goes beyond medical ...
RECENT POSTS
January 15, 2026
December 2, 2025
